In particular, 611-CTF is the most potent active truncated fragment of HER2 and heavily participates in in vivo BC progression and disease relapse by triggering multiple signaling cascades that lead to a continuous activation of the PI3K/Akt pathway [44]. This evidence concerns the gene ERBB2 and breast cancer.